Experiments were therefore designed to test whether cd45- [cd34+/kdr+]EPCs quantitatively and/or qualitatively decline with age, and test the converse whether juvenile EPCs contribute to “on-the-ready” real-time surveillance and endothelial repair critical for the maintenance of endothelial integrity, thus capable of delaying stroke onset. The gene discussed is CD34; the disease is Stroke.